Clinical Trial Update: Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase II study evaluating risk-adapted stereotactic body radiotherapy for early non-small cell lung cancer using the VERO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non-Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN